These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 25978841)
1. Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study. Lin CM; Huang HL; Chu FY; Fan HC; Chen HA; Chu DM; Wu LW; Wang CC; Chen WL; Lin SH; Ho SY PLoS One; 2015; 10(5):e0125421. PubMed ID: 25978841 [TBL] [Abstract][Full Text] [Related]
2. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan. Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711 [TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523 [TBL] [Abstract][Full Text] [Related]
4. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817 [TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. Liao KF; Lai SW; Li CI; Chen WC J Gastroenterol Hepatol; 2012 Apr; 27(4):709-13. PubMed ID: 21929650 [TBL] [Abstract][Full Text] [Related]
6. Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan. Lai SW; Liao KF; Chen PC; Tsai PY; Hsieh DP; Chen CC Clin Lung Cancer; 2012 Mar; 13(2):143-8. PubMed ID: 22129971 [TBL] [Abstract][Full Text] [Related]
7. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study. Lai HC; Lin CC; Cheng KS; Kao JT; Chou JW; Peng CY; Lai SW; Chen PC; Sung FC Gastroenterology; 2014 Jan; 146(1):129-37.e1. PubMed ID: 24095786 [TBL] [Abstract][Full Text] [Related]
8. Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study. Tseng YH; Tsan YT; Chan WC; Sheu WH; Chen PC Diabetes Care; 2015 Nov; 38(11):2068-74. PubMed ID: 26307605 [TBL] [Abstract][Full Text] [Related]
9. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus. Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104 [TBL] [Abstract][Full Text] [Related]
10. Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner. Tsai MJ; Yang CJ; Kung YT; Sheu CC; Shen YT; Chang PY; Huang MS; Chiu HC Lung Cancer; 2014 Nov; 86(2):137-43. PubMed ID: 25267165 [TBL] [Abstract][Full Text] [Related]
11. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK. Kowall B; Stang A; Rathmann W; Kostev K Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313 [TBL] [Abstract][Full Text] [Related]
12. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study. Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226 [TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies. Herrigel DJ; Moss RA Postgrad Med; 2014 Oct; 126(6):106-18. PubMed ID: 25414939 [TBL] [Abstract][Full Text] [Related]
14. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus]. Ozawa H; Murai Y; Ozawa T Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054 [TBL] [Abstract][Full Text] [Related]
15. Oral treatment for diabetes using α-glucosidase inhibitors was a risk factor for chronic obstructive pulmonary disease: a cohort study. Wu SW; Ho YC; Luo CW; Chen HY; Su CH; Kuan YH Int J Med Sci; 2021; 18(3):778-784. PubMed ID: 33437213 [No Abstract] [Full Text] [Related]
16. [Diabetes and cancer: an injurious association]. Gariani K; Tran C; Philippe J Rev Med Suisse; 2010 Jun; 6(252):1193-4, 1196-8. PubMed ID: 20614754 [TBL] [Abstract][Full Text] [Related]
17. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study. Lu HL; Su YC; Lin MC; Sun MF; Huang ST Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062 [TBL] [Abstract][Full Text] [Related]
18. Increased Risk of Herpes Zoster in Diabetic Patients Comorbid with Coronary Artery Disease and Microvascular Disorders: A Population-Based Study in Taiwan. Ke CC; Lai HC; Lin CH; Hung CJ; Chen DY; Sheu WH; Lui PW PLoS One; 2016; 11(1):e0146750. PubMed ID: 26751202 [TBL] [Abstract][Full Text] [Related]
19. Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan. Chen YL; Cheng KC; Lai SW; Tsai IJ; Lin CC; Sung FC; Lin CC; Chen PC Gastric Cancer; 2013 Jul; 16(3):389-96. PubMed ID: 23053824 [TBL] [Abstract][Full Text] [Related]
20. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database. Jiang YD; Chang CH; Tai TY; Chen JF; Chuang LM J Formos Med Assoc; 2012 Nov; 111(11):599-604. PubMed ID: 23217595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]